Erytech Pharma, MD Anderson Ink Companion Dx Deal | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (Genomeweb News) – French firm Erytech Pharma today said that it will collaborate with MD Anderson Cancer Center in Houston on the development of a companion diagnostic for the firm's anticancer drug candidate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.